Skip to main content
Elsevier
View Cart
openUserAccount

Books in Pharmacology

Elsevier's Pharmacology collection studies how drugs interact with biological systems to improve health and treat disease. It covers pharmacodynamics, exploring drug effects on biology, and pharmacokinetics, studying how the body affects drugs. Branches like Pharmacogenetics. Essential for pharmacologists, this collection offers invaluable insights into drug interactions, efficacy, and safety, crucial for advancing drug development and improving patient outcomes.

BooksJournals
171-180 of 531 results in All results

Side Effects of Drugs Annual

  • 1st Edition
  • Volume 38
  • October 25, 2016
  • Sidhartha D. Ray
  • English
  • Hardback
    9 7 8 - 0 - 4 4 4 - 6 3 7 1 8 - 5
  • eBook
    9 7 8 - 0 - 4 4 4 - 6 3 8 8 9 - 2
Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions was first published in 1977, and has been continually published as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs. Each annual provides clinicians and medical investigators with a reliable and critical survey of new data and trends in the area of adverse drug reactions and interactions, with an international team of specialists contributing their expertise each year.

Cardioskeletal Myopathies in Children and Young Adults

  • 1st Edition
  • October 22, 2016
  • John Lynn Jefferies + 3 more
  • English
  • Hardback
    9 7 8 - 0 - 1 2 - 8 0 0 0 4 0 - 3
  • eBook
    9 7 8 - 0 - 1 2 - 8 0 0 5 8 0 - 4
Cardioskeletal Myopathies in Children and Young Adults focuses on plaques that kill people in their 40’s-50’s and the way they start to form in young adulthood. The Annals of Family Medicine report that approximately half of young adults have at least one cardiovascular disease risk factor (Mar 2010), and an increase in cardiovascular mortality rates in young adults was substantiated in a study at Northwestern Medicine (Nov 2011). Given the increasing recognition of genetic triggers behind all types of cardiovascular disease, and the growing population of young adults with primary or acquired myocardial disease, the need has arisen for a reference that offers a comprehensive approach to the understanding of basic, translational, and clinical aspects of specific muscle diseases while making the link between young adult and adult health.

Pharmacology in Drug Discovery and Development

  • 2nd Edition
  • October 21, 2016
  • Terry P. Kenakin
  • English
  • Paperback
    9 7 8 - 0 - 1 2 - 8 0 3 7 5 2 - 2
  • eBook
    9 7 8 - 0 - 1 2 - 8 0 3 7 5 3 - 9
Pharmacology in Drug Discovery and Development: Understanding Drug Response, Second Edition, is an introductory resource illustrating how pharmacology can be used to furnish the tools necessary to analyze different drug behavior and trace this behavior to its root cause or molecular mechanism of action. The concepts discussed in this book allow for the application of more predictive pharmacological procedures aimed at increasing therapeutic efficacy that will lead to more successful drug development. Chapters logically build upon one another to show how to characterize the pharmacology of any given molecule and allow for more informed predictions of drug effects in all biological systems. New chapters are dedicated to the interdisciplinary drug discovery environment in both industry and academia, and special techniques involved in new drug screening and lead optimization. This edition has been fully revised to address the latest advances and research related to real time kinetic assays, pluridimensional efficacy, signaling bias, irreversible and chemical antagonism, allosterically-induced bias, pharmacokinetics and safety, target and pathway validation, and much more. With numerous valuable chapter summaries, detailed references, practical examples and case studies throughout, Dr. Kenakin successfully navigates a highly complex subject, making it accessible for students, professors, and new researchers working in pharmacology and drug discovery.

Anticandidal Agents

  • 1st Edition
  • September 12, 2016
  • Awanish Kumar
  • English
  • Paperback
    9 7 8 - 0 - 1 2 - 8 1 1 3 1 1 - 0
  • eBook
    9 7 8 - 0 - 1 2 - 8 1 1 3 1 2 - 7
Anticandidal Agents provides the latest information on candida drug resistance and its remedial implications. In this compilation, users will find a comprehensive view on overcoming resistance in anticandidal drugs, along with information on novel molecules. Candida albicans is an opportunistic pathogenic fungus responsible for life threating invasive and nosocomial infections across the globe. Candidiasis is a major cause of morbidity among immunocompromised patients. Infections caused by non-albicans candida like C. glabrata, C. parapsilosis, and C. tropicalis have also imposed a serious threat in the last few decades. Current treatment of candidiasis relies primarily on antifungal agents broadly categorized as azoles, polyenes, echinocandins, allylamines, and pyrimidines. Lately, antifungal resistance has emerged to be an obstruction of current treatment regime. A number of reasons are described in detail. Understanding the mechanisms of resistance is crucial for developing strategies for overcoming the hindrance in current therapeutics.

Life-Threatening Effects of Antipsychotic Drugs

  • 1st Edition
  • August 12, 2016
  • Peter Manu + 2 more
  • English
  • Hardback
    9 7 8 - 0 - 1 2 - 8 0 3 3 7 6 - 0
  • eBook
    9 7 8 - 0 - 1 2 - 8 0 3 3 9 0 - 6
Life-Threatening Effects of Antipsychotic Drugs describes in detail more than 20 life-threatening effects associated with antipsychotics, presents the best available data on their incidence and case fatality, and gives comprehensive advice on diagnosis, management and preventive strategies. In addition, the book discusses the benefit of antipsychotic medication in a range of therapeutic indications, and demonstrates the gain in life-expectancy associated with clozapine use in severe mental illness despite its serious, potentially life-threatening adverse effects.

Regenerative Medicine for Peripheral Artery Disease

  • 1st Edition
  • June 13, 2016
  • Emile R Mohler + 1 more
  • English
  • Hardback
    9 7 8 - 0 - 1 2 - 8 0 1 3 4 4 - 1
  • eBook
    9 7 8 - 0 - 1 2 - 8 0 1 4 8 7 - 5
Regenerative Medicine for Peripheral Artery Disease is a comprehensive and up-to-date resource on the use of regenerative medicine for the treatment of peripheral arterial disease. This reference includes a general overview of regenerative medicine and covers important vascular topics, including intermittent claudication and critical limb ischemia, with important mechanisms clearly presented in full color images throughout the book. This important reference includes clear and concise information on both human clinical trials, as well as important and pertinent animal studies, and is a must-have reference for researchers and practitioners of peripheral artery disease.

Pyrantel Parasiticide Therapy in Humans and Domestic Animals

  • 1st Edition
  • June 2, 2016
  • Alan A. Marchiondo
  • English
  • Paperback
    9 7 8 - 0 - 1 2 - 8 0 1 4 4 9 - 3
  • eBook
    9 7 8 - 0 - 1 2 - 8 0 1 6 9 2 - 3
Pyrantel Parasiticide Therapy in Humans and Domestic Animals presents a single source history and reference on the parasiticide activity and pharmacology of the tetrahydropyrimidines and their salts in humans and domestic animals, also collating evidence that resistance to pyrantel has developed in human and domestic animal nematodes. Other books of this nature have been compiled historically for specific anthelmintic compounds, but none has been written to date for the pyrantel family of drugs. Pyrantel, a nicotinic receptor agonist, has been used in domestic animal and human medicine since the 1970’s to control two important nematode groups, the hookworms and the roundworms. Given the zoonotic potential of these parasites, pyrantel has served a dual role in helping to protect the health of both domestic animals and the public for more than 45 years.

Lanzkowsky's Manual of Pediatric Hematology and Oncology

  • 6th Edition
  • April 22, 2016
  • Jonathan D. Fish + 2 more
  • English
  • eBook
    9 7 8 - 0 - 1 2 - 8 0 1 6 7 4 - 9
Lanzkowsky’s Manual of Pediatric Hematology and Oncology, Sixth Edition, is a comprehensive book on patient management, replete with algorithms and flow diagrams on diagnosis and management. Reflecting the considerable advances in the treatment and management of hematologic and oncologic diseases in children, the sixth edition of this successful clinical manual has been entirely updated to incorporate all current treatment protocols, new drugs, and management approaches. Its concise and easy-to-read format will enable readers to make accurate diagnoses and permit them to treat patients without having to reference larger medical textbooks. Based on the new standards of genetic classification and prognostic information that have arisen in the past five years, the sixth edition includes two new chapters (Diagnostic, Molecular, and Genomic Methodologies for the Hematologist, Transfusion Medicine) and several new expanded chapters that were previously sections in consolidated chapters (Myelodysplasia, Myeloid Leukemias, Lymphoid Leukemias, Hemolytic Anemia, and Disorders of Coagulation).

Psychopharmacology of Anxiolytics and Antidepressants

  • 1st Edition
  • April 20, 2016
  • S.E. File
  • English
  • eBook
    9 7 8 - 1 - 4 8 3 2 - 8 7 5 2 - 2
Contributed volume reviewing the clinical and animal literature related to the pharmacology of anxiety and depression. The role of the hypothalmic-pituitary-adrenal axis in anxiety and depression is reviewed as well as the response of central catecholamines to chronic stress.

Cardiac MRI in Diagnosis, Clinical Management, and Prognosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia

  • 1st Edition
  • March 4, 2016
  • Aiden Abidov + 2 more
  • English
  • Paperback
    9 7 8 - 0 - 1 2 - 8 0 1 2 8 3 - 3
  • eBook
    9 7 8 - 0 - 1 2 - 8 0 1 4 3 5 - 6
Cardiac MRI in Diagnosis, Clinical Management and Prognosis of Arrhythmogenic Right Ventricular Cardiomyopathy / Dysplasia provides up-to-date information regarding the most effective diagnostic protocols and CMR sequences for the evaluation of patients with suspected or known ARVC/D. It includes CMR protocol summaries and clinical algorithms presented as flow diagrams, many of which have never been previously published. The book contains case reports from the practice and database of Dr. Frank I. Marcus, world renowned ARVC/D expert; as well as input from imaging experts from a large academic center with unique RV pathology imaging experience. This title is the perfect pocket companion for cardiologists, pediatric cardiologists, cardiac imaging and electrophysiology specialists as well as cardiology researchers.

Related subjects

Biochemical pharmacology

Cardiovascular pharmacology

Clinical pharmacology therapeutics

Clinical trials

Drug adverse reactions and interactions

Endocrine exocrine pharmacology

Ethnopharmacology

Gastrointestinal pharmacology

Immunopharmacology pharmacology

Molecular pharmacology

Neoplastic cancer pharmacology

Pharmacokinetics pharmacodynamics

Pharmacology general

Psychoneuropharmacology

Pulmonary pharmacology

Renal and electrolyte pharmacology